10-15 Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.41M Sell
27,020
-993
-4% -$88K 0.47% 52
2020
Q2
$2.16M Buy
28,013
+405
+1% +$27.5K 0.44% 50
2020
Q1
$1.56M Buy
27,608
+2,417
+10% +$185K 0.36% 57
2019
Q4
$1.84M Sell
25,191
-1,287
-5% -$85.9K 0.35% 61
2019
Q3
$1.84M Buy
26,478
+2,362
+10% +$161K 0.38% 56
2019
Q2
$1.7M Buy
24,116
+1,280
+6% +$94.5K 0.37% 56
2019
Q1
$1.87M Buy
22,836
+676
+3% +$55.3K 0.4% 53
2018
Q4
$1.71M Buy
22,160
+390
+2% +$36.8K 0.42% 50
2018
Q3
$2.17M Buy
21,770
+970
+5% +$93.9K 0.49% 51
2018
Q2
$1.96M Buy
20,800
+2,080
+11% +$200K 0.44% 55
2018
Q1
$1.74M Buy
+18,720
New +$2.06M 0.41% 54

Other funds holding ALB

10-15 Associates's ALB Position: Q3 2020 in Review

10-15 Associates reduced its Albemarle (ALB) stake by 3.5% in Q3 2020, selling an estimated $88K and leaving 27,020 shares worth $2.41M. The position accounts for 0.47% of the portfolio, ranked #52.

10-15 Associates first reported a position in ALB in Q1 2018 and has held it in 11 quarters since. 575 funds tracked by Wall St. Rank hold ALB as of Q3 2020.

  • 10-15 Associates held 27,020 shares of Albemarle worth $2.41M as of Q3 2020.
  • 10-15 Associates sold 993 Albemarle shares in Q3 2020, an estimated $88K.
  • Albemarle made up 0.47% of 10-15 Associates's portfolio in Q3 2020, its #52 holding.
  • 10-15 Associates first reported a position in Albemarle in Q1 2018 and has held it in 11 quarters since.
  • 575 funds tracked by Wall St. Rank held Albemarle as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.